Scientific Advisory Board
Jose Arribas MD, is the Senior Attending Physician at the HIV Unit of the Hospital de La Paz in Madrid and has acted as principal investigator for a number of HIV clinical trials.
Pedro Cahn MD PhD, is Director of Fundación Huesped in Buenos Aires, Chief of the Infectious Disease Unit at Juan A. Fernandez Hospital, Assistant Professor in Infectious Diseases at the Buenos Aires University Medical School and past President of the International AIDS Society. He was co-chair of the 4th IAS Conference on HIV Pathogenesis and Treatment. He has chaired the Argentinean AIDS Society and the AIDS Committee of the Pan-American Society of Infectious Diseases.
David Cooper AO FAA, MD, DSc is Director of the National Centre in HIV Epidemiology and Clinical Research, Sydney, Head of the Immunology/HIV/Infectious Diseases Clinical Service Unit at St Vincent’s Hospital, Sydney and Professor of Medicine at the University of New South Wales. He is a past President of the International AIDS Society (IAS) and was co-chair of the 4th IAS Conference on HIV Pathogenesis and Treatment.
Joe Eron MD, is Professor of Medicine in the Division of Infectious Diseases at the University of North Carolina Chapel Hill School of Medicine. He is Principal Investigator of the UNC AIDS Clinical Research Group and Director of the UNC Center for AIDS Research (CFAR) Clinical Core.
Brian Gazzard MD is Consultant Physician and Research Director of HIV/GUM, St. Stephen’s Clinic, Chelsea and Westminster Hospital, London and Professor of HIV medicine. He was founding chairman of the British HIV Association (BHIVA).
Daniel R. Kuritzkes, MD, is a Professor of Medicine at Harvard Medical School and Head Director of the AIDS Research section of Retroviral Therapeutics at Brigham & Women’s Hospital in Boston. He is also Vice Chair of the Executive Committee of the Adult AIDS Clinical Trials Group (ACTG) and Director and Principal Investigator of the Harvard Adult AIDS Clinical Trials Unit.
Joep Lange MD PhD is Professor of Internal Medicine, Academic Medical Centre,
University of Amsterdam, Director of the National AIDS Therapy Evaluation Centre, Senior Scientific Advisor of International Antiviral Therapy Evaluation Centre and Chairman of PharmAccess International Foundation. He is a past chief of the World Health Organization's Clinical Research and Product Development branch of the Global Programme on AIDS.
Rob Murphy MD is Associate Professor of Medicine and Clinical Coordinator of the AIDS Biopsychosocial Center at Northwestern University Medical School. He is also Medical Director of the AIDS and STD Clinics, as well as Attending Physician, at Northwestern Memorial Hospital in Chicago.
François Raffi MD PhD is Professor of Infectious and Tropical Diseases at Nantes Medical University, Head of the Infectious and Tropical Diseases Unit and Head of the AIDS Clinical Research Unit and AIDS Reference Center in Nantes. He is a member of the French Agency for AIDS Research (ANRS) and the European AIDS Clinical Society Executive Committee.
Michael S. Saag, MD is on the Board of Directors of the International AIDS Society–USA holds the Jim Straley Chair in AIDS Research and is Professor of Medicine and Director of the Center for AIDS Research at the University of Alabama. Principal Investigator of the Phase 2b/3 AVX-301 trial.
Mark A. Wainberg, OC, OQ, FRSC, is the Director of the McGill University AIDS Centre at the Montreal Jewish General Hospital and Professor of Medicine and of Microbiology at McGill University.
